DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 12-Month Low - Here's What Happened

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) hit a new 52-week low during trading on Tuesday . The stock traded as low as $12.54 and last traded at $12.59, with a volume of 1974111 shares. The stock had previously closed at $13.24.

Analysts Set New Price Targets

Several research firms have weighed in on XRAY. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Evercore ISI reaffirmed an "in-line" rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Barrington Research lowered their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Finally, Mizuho reduced their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research report on Thursday, March 13th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $23.33.

Remove Ads

DENTSPLY SIRONA Stock Performance

The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The company has a market cap of $2.54 billion, a P/E ratio of -6.17, a P/E/G ratio of 1.80 and a beta of 0.92. The stock's fifty day moving average price is $16.21 and its two-hundred day moving average price is $19.10.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 5.01%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's payout ratio is presently -14.07%.

Insider Activity

In related news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.52% of the company's stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently added to or reduced their stakes in XRAY. Vanguard Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock worth $383,078,000 after buying an additional 65,478 shares in the last quarter. First Eagle Investment Management LLC grew its position in DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock worth $275,218,000 after acquiring an additional 348,532 shares during the last quarter. Nuance Investments LLC increased its holdings in DENTSPLY SIRONA by 25.0% in the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after purchasing an additional 1,975,404 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in shares of DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after purchasing an additional 314,343 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.